State product liability laws traditionally hold manufacturers, distributors, and sellers strictly liable for defective products they bring to market. As consumers increasingly make purchases from online marketplaces—platforms that aggregate products from multiple third-party sellers—new questions arise about how to best protect them from defective products that pose a risk to health and safety.

America desperately needs a federal privacy law—but it needs the right federal privacy law. In its current state, APRA is not that law. But with a few important changes, it could be.

Protecting children from online harms requires a careful balance between ensuring safety and safeguarding free speech, user privacy, and parents’ rights. The most effective approach would split responsibility between the government, parents, and online services.

Given the potential for countries to reshore and automate previously outsourced IT occupations, the Global South’s IT services appear vulnerable to the displacing effects of AI. Yet, existing policy responses may be insufficient to address that challenge.

Some concerns are legitimate, but others are not. Some require immediate regulatory responses, but many do not. And a few require regulations addressing AI specifically, but most do not.

In a nationally representative survey of more than 2,000 U.S. adults, Public First and the Center for Data Innovation track public attitudes and perceptions of artificial intelligence.

Vibrant regional energy innovation ecosystems are important for any national net-zero strategy. But to understand the potential contributions they can make to the price and performance of clean energy technologies, we must first benchmark the resources they bring to bear.

Despite claims by anticorporate neo-Brandeisians, corporate concentration appears positively correlated with higher productivity and wages. So, the push to break up large companies is antiworker and anti-middle class.

Congress has allocated $42.5 billion to bridge America’s digital divide through the Broadband Equity, Access and Deployment (BEAD) program. To achieve that goal, states and territories must carefully craft plans to use their shares of the funds to the greatest possible benefit.

Larger firms are generally more productive because of scale economies, but some U.S. industries still have too high a share of small firms. Policymakers should encourage, not discourage, greater consolidation in these industries.

Canada faces unprecedented challenges in innovation, productivity, and competitiveness. The first step in addressing them is to develop a clear understanding of the Canadian economy’s underlying structure and performance in each area. Policymakers must then tailor strategies for specific industries and technologies instead of focusing on principally on macro factors.

Better evidence is needed to evaluate the impact of policy changes on new drug development. Greater availability of government data should support more rigorous evaluations to inform evidence-based policymaking.

Alone, America cannot stem Beijing’s rise in advanced industries. We need a new pact with Europe. Its objective should be to refuse to surrender to technological domination by the CCP. Being pioneers of the green transition will not be enough.

Global data and technology governance will be challenging without cooperation on cloud trustworthiness. Policymakers should avoid simplistic assessments based on nationality and instead develop more holistic assessments based on legal and technical criteria.

China is leading in chemical production, especially basic chemicals. And while it is currently lagging behind on innovation—especially in more complex fine chemicals—all signs suggest it will catch up with the global leaders within the next decade or two.

With the gradual shift from internal combustion to electric vehicles, it is only a matter of time before the nation will have to replace gas taxes with a vehicle miles traveled system to pay for road maintenance. The most sensible way to start would be with heavy trucks.

The United States and European Union should work through the Trade and Technology Council to align their respective cybersecurity labeling programs for the Internet of Things rather than allowing IoT security to become another technical barrier to trade and technology cooperation.

A report by the Economic Innovation Group (EIG) concludes that declining knowledge diffusion is the underlying cause of declining business dynamism. However, its theoretical model is based on flawed assumptions, while its mathematical model has methodological issues.

China does not yet appear to be leading in robotic innovation, but its domestic production and adoption are growing rapidly, and the Chinese government has prioritized the industry. It is likely only a matter of time before Chinese robotics companies catch up to the leading edge.

America’s leadership in advanced-technology industries can never be taken for granted, as evidenced by its losses in telecommunications equipment, semiconductors, televisions, solar panels, and chemicals. Policymakers must recognize what went wrong in those cases to avoid a similar industrial decline in the biopharmaceutical industry.

In areas ranging from data privacy to content moderation, states are creating patchworks of regulation that confuse consumers, complicate compliance, and undermine the digital economy. It’s time for Congress to step in and establish a consistent national approach to digital policy.

India has the potential to play a much more significant role in global semiconductor value chains, provided the government upholds its investment policies, maintains a conducive regulatory and business environment, and avoids measures that create unpredictability.

Neoliberalism’s deficiencies are clear. To address the challenges America now faces, policymakers should adopt the doctrine of national developmentalism and not allow economic policy to swing back toward a revised New Dealism, as it is now doing.

China now dominates the strategically important industries in ITIF’s Hamilton Index, producing more than any other nation in absolute terms and more than all but a few others in relative terms. Its gains are coming at the expense of the United States and other G7 and OECD economies, and time is running short for policymakers to mount an industrial comeback.

A recent article in the British Medical Journal contends “high drug prices” are neither necessary nor justified to sustain biopharmaceutical innovation. But it misrepresents and misinterprets the facts, highlighting how faulty the rationale is for drug price controls.